CHEMOTHERAPY INDUCED NEUTROPENIA

Clinical trials for CHEMOTHERAPY INDUCED NEUTROPENIA explained in plain language.

Never miss a new study

Get alerted when new CHEMOTHERAPY INDUCED NEUTROPENIA trials appear

Sign up with your email to follow new studies for CHEMOTHERAPY INDUCED NEUTROPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Completed 1 Terminated 1

Bladder cancer trial halted: could trilaciclib have saved bone marrow?

Disease control Terminated

This phase 2 trial tested whether adding trilaciclib (Cosela) to standard chemotherapy and avelumab could help people with advanced bladder cancer by protecting their bone marrow. The study enrolled 92 adults with untreated, locally advanced or metastatic urothelial carcinoma. Un…

Matched conditions: CHEMOTHERAPY INDUCED NEUTROPENIA

Phase: PHASE2 • Sponsor: G1 Therapeutics, Inc. • Aim: Disease control

Last updated Jun 26, 2026 15:04 UTC

CHEMOTHERAPY INDUCED NEUTROPENIA

Get alerted when new CHEMOTHERAPY INDUCED NEUTROPENIA trials appear

Bladder cancer trial halted: could trilaciclib have saved bone marrow?